Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 Expression. - Kong BL; Stommel JM; Keck JM; Kilburn D; Streblow A; Egger J; Creason AL; Suciu CG; Guimaraes AR; Corless CL; Mills GB; Pejovic TB (JCO precision oncology, 2024)